Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Connected Medical Devices Market

ID: MRFR/MED/14210-HCR
100 Pages
Rahul Gotadki
Last Updated: April 24, 2026

์—ฐ๊ฒฐ๋œ ์˜๋ฃŒ๊ธฐ๊ธฐ ์‹œ์žฅ ์กฐ์‚ฌ ๋ณด๊ณ ์„œ โ€“ 2032๋…„ ์˜ˆ์ธก

๊ณต์œ 
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Connected Medical Devices Market Infographic
Purchase Options
  1. 2.1 ์ •์˜
    1. 2.2 ์—ฐ๊ตฌ ๋ฒ”์œ„
      1. 2.2.1 ์—ฐ๊ตฌ ๋ชฉ์ 
      2. 2.2.2 ๊ฐ€์ •
      3. 2.2.3 ์ œํ•œ ์‚ฌํ•ญ
    2. 3.1 ์„œ๋ก 
    3. 3.2 1์ฐจ ์—ฐ๊ตฌ
    4. 3.3 2์ฐจ ์—ฐ๊ตฌ
    5. 3.4 ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •
    6. 4.1 ๋™์ธ
    7. 4.2 ์ œ์•ฝ
    8. 4.3 ๊ธฐํšŒ
    9. 4.4 ๊ณผ์ œ
    10. 4.5 ๊ฑฐ์‹œ๊ฒฝ์ œ ์ง€ํ‘œ
    11. 4.6 ๊ธฐ์ˆ  ๋™ํ–ฅ ๋ฐ amp; ํ‰๊ฐ€
    12. 5.1 ํฌํ„ฐ์˜ 5๊ฐ€์ง€ ํž˜ ๋ถ„์„
      1. 5.1.1 ๊ณต๊ธ‰์ž์˜ ๊ต์„ญ๋ ฅ
      2. 5.1.2 ๊ตฌ๋งค์ž์˜ ๊ต์„ญ๋ ฅ
      3. 5.1.3 ์‹ ๊ทœ ์ง„์ž…์ž์˜ ์œ„ํ˜‘
      4. 5.1.4 ๋Œ€์ฒด ์œ„ํ˜‘
      5. 5.1.5 ๊ฒฝ์Ÿ์˜ ๊ฐ•๋„
    13. 5.2 ๊ฐ€์น˜ ์‚ฌ์Šฌ ๋ถ„์„
    14. 5.3 ํˆฌ์ž ํƒ€๋‹น์„ฑ ๋ถ„์„
    15. 5.4 ๊ฐ€๊ฒฉ ๋ถ„์„
    16. 6.1 ์†Œ๊ฐœ
    17. 6.2 ECG ๋ชจ๋‹ˆํ„ฐ๋ง ์žฅ์น˜
    18. 6.3 ์ธ์А๋ฆฐ ํŽŒํ”„
    19. 6.4 BP ๋ชจ๋‹ˆํ„ฐ
    20. 6.5 ํœด๋Œ€์šฉ GPS PERS
    21. 6.6 ํ˜ˆ๋‹น ๋ชจ๋‹ˆํ„ฐ
    22. 6.7 ๋งฅ๋ฐ• ์‚ฐ์†Œ ๋†๋„๊ณ„
    23. 6.8 ์Šค๋งˆํŠธ ์•Œ์•ฝ ๋””์ŠคํŽœ์„œ
    24. 6.9 ์‹ฌ๋ฐ•์ˆ˜ ๋ชจ๋‹ˆํ„ฐ
    25. 6.10 ๊ธฐํƒ€
    26. 7.1 ์†Œ๊ฐœ
    27. 7.2 ์›จ์–ด๋Ÿฌ๋ธ”
    28. 7.3 ๋น„์›จ์–ด๋Ÿฌ๋ธ”
    29. 8.1 ์†Œ๊ฐœ
    30. 8.2 ์›๊ฒฉ ๋ชจ๋‹ˆํ„ฐ๋ง
    31. 8.3 ์ƒ๋‹ด ๋ฐ ์ง„๋‹จ ์„œ๋น„์Šค
    32. 8.4 ์น˜๋ฃŒ ์„œ๋น„์Šค
    33. 8.5 ํ”ผํŠธ๋‹ˆ์Šค ๋ฐ ์›ฐ๋‹ˆ์Šค ์„œ๋น„์Šค
    34. 9.1 ์†Œ๊ฐœ
    35. 9.2 ๋ณ‘์›
    36. 9.3 ์™ธ๋ž˜ ์ˆ˜์ˆ  ์„ผํ„ฐ
    37. 9.4 ์ „๋ฌธ ํด๋ฆฌ๋‹‰
    38. 9.5 ํ™ˆ ์ผ€์–ด ์„ค์ •/๋ชจ๋‹ˆํ„ฐ๋ง
    39. 9.6 ๊ธฐํƒ€
    40. 10.1 ์†Œ๊ฐœ
    41. 10.2 ๋ฏธ์ฃผ
      1. 10.2.1 ๋ถ๋ฏธ
        1. 10.2.1.1 ๋ฏธ๊ตญ
        2. 10.2.1.2 ์บ๋‚˜๋‹ค
      2. 10.2.2 ๋‚จ๋ฏธ
    42. 10.3 ์œ ๋Ÿฝ
      1. 10.3.1 ์„œ์œ ๋Ÿฝ
        1. 10.3.1.1 ๋…์ผ
        2. 10.3.1.2 ํ”„๋ž‘์Šค
        3. 10.3.1.3 ์ดํƒˆ๋ฆฌ์•„
        4. 10.3.1.4 ์ŠคํŽ˜์ธ
        5. 10.3.1.5 ์˜๊ตญ
        6. 10.3.1.6 ๋‚˜๋จธ์ง€ ์„œ์œ ๋Ÿฝ
      2. 10.3.2 ๋™์œ ๋Ÿฝ
    43. 10.4 ์•„์‹œ์•„ ํƒœํ‰์–‘
      1. 10.4.1 ์ผ๋ณธ
      2. 10.4.2 ์ค‘๊ตญ
      3. 10.4.3 ์ธ๋„
      4. 10.4.4 ํ˜ธ์ฃผ
      5. 10.4.5 ํ•œ๊ตญ
      6. 10.4.6 ๋‚˜๋จธ์ง€ ์•„์‹œ์•„ ํƒœํ‰์–‘
    44. 10.5 ์ค‘๋™ ๋ฐ amp; ์•„ํ”„๋ฆฌ์นด
      1. 10.5.1 ์ค‘๋™
      2. 10.5.2 ์•„ํ”„๋ฆฌ์นด
    45. 11.1 ์†Œ๊ฐœ
    46. 11.2 ์‹œ์žฅ ์ ์œ ์œจ ๋ถ„์„
    47. 11.3 ์ฃผ์š” ๊ฐœ๋ฐœ ๋ฐ amp; ์ „๋žต
    48. 12.1 GE Healthcare, Inc.
      1. 12.1.1 ํšŒ์‚ฌ ๊ฐœ์š”
      2. 12.1.2 ์ œํ’ˆ ๊ฐœ์š”
      3. 12.1.3 ์žฌ๋ฌด ๊ฐœ์š”
      4. 12.1.4 ์ฃผ์š” ๊ฐœ๋ฐœ
      5. 12.1.5 SWOT ๋ถ„์„
    49. 12.2 Medtronic Plc
      1. 12.2.1 ํšŒ์‚ฌ ๊ฐœ์š”
      2. 12.2.2 ์ œํ’ˆ ๊ฐœ์š”
      3. 12.2.3 ์žฌ๋ฌด ๊ฐœ์š”
      4. 12.2.4 ์ฃผ์š” ๊ฐœ๋ฐœ
      5. 12.2.5 SWOT ๋ถ„์„
    50. 12.3 OMRON Corporation
      1. 12.3.1 ํšŒ์‚ฌ ๊ฐœ์š”
      2. 12.3.2 ์ œํ’ˆ ๊ฐœ์š”
      3. 12.3.3 ์žฌ๋ฌด ๊ฐœ์š”
      4. 12.3.4 ์ฃผ์š” ๊ฐœ๋ฐœ
      5. 12.3.5 SWOT ๋ถ„์„
    51. 12.4 Philips Healthcare
      1. 12.4.1 ํšŒ์‚ฌ ๊ฐœ์š”
      2. 12.4.2 ๊ธฐ์ˆ /์‚ฌ์—… ๋ถ€๋ฌธ ๊ฐœ์š”
      3. 12.4.3 ์žฌ๋ฌด ๊ฐœ์š”
      4. 12.4.4 ์ฃผ์š” ๊ฐœ๋ฐœ
      5. 12.4.5 SWOT ๋ถ„์„
    52. 12.5 McKesson Corporation
      1. 12.5.1 ํšŒ์‚ฌ ๊ฐœ์š”
      2. 12.5.2 ์ œํ’ˆ ๊ฐœ์š”
      3. 12.5.3 ์žฌ๋ฌด ๊ฐœ์š”
      4. 12.5.4 ์ฃผ์š” ๊ฐœ๋ฐœ
      5. 12.5.5 SWOT ๋ถ„์„
    53. 12.6 Fitbit, Inc.
      1. 12.6.1 ํšŒ์‚ฌ ๊ฐœ์š”
      2. 12.6.2 ์ œํ’ˆ ๊ฐœ์š”
      3. 12.6.3 ์žฌ๋ฌด ๊ฐœ์š”
      4. 12.6.4 ์ฃผ์š” ๊ฐœ๋ฐœ
      5. 12.6.5 SWOT ๋ถ„์„
    54. 12.7 Johnson & Johnson
      1. 12.7.1 ๊ฐœ์š”
      2. 12.7.2 ์ œํ’ˆ ๊ฐœ์š”
      3. 12.7.3 ์žฌ๋ฌด ๊ฐœ์š”
      4. 12.7.4 ์ฃผ์š” ๊ฐœ๋ฐœ
      5. 12.7.5 SWOT ๋ถ„์„
    55. 12.8 Boston Scientific Corporation
      1. 12.8.1 ๊ฐœ์š”
      2. 12.8.2 ์ œํ’ˆ/๊ธฐ์ˆ  ๊ฐœ์š”
      3. 12.8.3 ์žฌ๋ฌด
      4. 12.8.4 ์ฃผ์š” ๊ฐœ๋ฐœ
      5. 12.8.5 SWOT ๋ถ„์„
    56. 12.9 St. Jude Medical, Inc.(Abbott)
      1. 12.9.1 ๊ฐœ์š”
      2. 12.9.2 ์ œํ’ˆ ๊ฐœ์š”
      3. 12.9.3 ์žฌ๋ฌด
      4. 12.9.4 ์ฃผ์š” ๊ฐœ๋ฐœ
      5. 12.9.5 SWOT ๋ถ„์„
    57. 12.10 AgaMatrix, Inc.
      1. 12.10.1 ๊ฐœ์š”
      2. 12.10.2 ์ œํ’ˆ ๊ฐœ์š”
      3. 12.10.3 ์žฌ๋ฌด
      4. 12.10.4 ์ฃผ์š” ๊ฐœ๋ฐœ
      5. 12.10.5 SWOT ๋ถ„์„
    58. 12.11 Dexcom
      1. 12.11.1 ๊ฐœ์š”
      2. 12.11.2 ์ œํ’ˆ ๊ฐœ์š”
      3. 12.11.3 ์žฌ๋ฌด
      4. 12.11.4 ์ฃผ์š” ๊ฐœ๋ฐœ
      5. 12.11.5 SWOT ๋ถ„์„
    59. 12.12 F. Hoffmann-La Roche
      1. 12.12.1 ๊ฐœ์š”
      2. 12.12.2 ์ œํ’ˆ ๊ฐœ์š”
      3. 12.12.3 ์žฌ๋ฌด
      4. 12.12.4 ์ฃผ์š” ๊ฐœ๋ฐœ
      5. 12.12.5 SWOT ๋ถ„์„
    60. 12.13 Polar Electro
      1. 12.13.1 ๊ฐœ์š”
      2. 12.13.2 ์ œํ’ˆ ๊ฐœ์š”
      3. 12.13.3 ์žฌ๋ฌด
      4. 12.13.4 ์ฃผ์š” ๊ฐœ๋ฐœ
      5. 12.13.5 SWOT ๋ถ„์„
    61. 12.14 IHealth Labs(Andon Health ์žํšŒ์‚ฌ)
      1. 12.14.1 ๊ฐœ์š”
      2. 12.14.2 ์ œํ’ˆ ๊ฐœ์š”
      3. 12.14.3 ์žฌ๋ฌด
      4. 12.14.4 ์ฃผ์š” ๊ฐœ๋ฐœ
      5. 12.14.5 SWOT ๋ถ„์„
    62. 12.15 Aerotel Medical Systems Ltd
      1. 12.15.1 ๊ฐœ์š”
      2. 12.15.2 ์ œํ’ˆ ๊ฐœ์š”
      3. 12.15.3 ์žฌ๋ฌด
      4. 12.15.4 ์ฃผ์š” ๊ฐœ๋ฐœ
      5. 12.15.5 SWOT ๋ถ„์„
    63. 13.1 ์ฃผ์š” ์กฐ์‚ฌ ๊ฒฐ๊ณผ
      1. 13.1.1 CEO ๊ด€์ 
      2. 13.1.2 ์‹œ์žฅ์˜ ์ถฉ์กฑ๋˜์ง€ ์•Š์€ ์š”๊ตฌ
    64. 13.2 ์ฃผ๋ชฉํ•ด์•ผ ํ•  ์ฃผ์š” ํšŒ์‚ฌ
    65. 13.3 ์—ฐ๊ฒฐ๋œ ์˜๋ฃŒ ๊ธฐ๊ธฐ ์‚ฐ์—…์— ๋Œ€ํ•œ ์˜ˆ์ธก
Case Study Cover Image
์‚ฌ๋ก€ ์—ฐ๊ตฌ

Aerospace & Defense

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization โœ“ โœ“ โœ“
Direct Access to Analyst โœ“ โœ“ โœ“
Deliverable Format โœ“ โœ“ โœ“
Platform Access โœ— โœ— โœ“
Discount on Next Purchase 10% 15% 15%
Printable Versions โœ— โœ— โœ“